BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 15110581)

  • 1. Liver transplantation from old donors into HCV and non-HCV recipients.
    Baccarani U; Adani GL; Toniutto P; Sainz M; Lorenzin D; Viale PL; Ramacciato G; Risaliti A; Bresadola F
    Transplant Proc; 2004 Apr; 36(3):527-8. PubMed ID: 15110581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elderly donors for HCV(+) versus non-HCV recipients: patient survival following liver transplantation.
    Boin IF; Ataide EC; Leonardi MI; Stucchi R; Sevá-Pereira T; Pereira IW; Cardoso AR; Caruy CA; Luzo A; Leonardi LS
    Transplant Proc; 2008 Apr; 40(3):792-6. PubMed ID: 18455019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of donor age on the results of liver transplantation in hepatitis C virus-positive recipients.
    Pérez-Daga JA; Ramírez-Plaza C; Suárez MA; Santoyo J; Fernández-Aguilar JL; Aranda JM; Sánchez-Pérez B; González-Sánchez A; Alvárez A; Valle M; Bondía JA
    Transplant Proc; 2008 Nov; 40(9):2959-61. PubMed ID: 19010159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of donor age on survival and fibrosis progression in patients with hepatitis C undergoing liver transplantation using HCV+ allografts.
    Khapra AP; Agarwal K; Fiel MI; Kontorinis N; Hossain S; Emre S; Schiano TD
    Liver Transpl; 2006 Oct; 12(10):1496-503. PubMed ID: 16964597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. UNOS Liver Registry: ten year survivals.
    Waki K
    Clin Transpl; 2006; ():29-39. PubMed ID: 18368704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of donor variables on the outcome of orthotopic liver transplantation for hepatitis C.
    Yagci G; Fernandez LA; Knechtle SJ; D'Alessandro AM; Chin LT; Musat AI; Lucey MR; Said A; Pirsch JD; Leverson G; Kalayoglu M
    Transplant Proc; 2008; 40(1):219-23. PubMed ID: 18261591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transplantation of liver grafts from older donors: impact on recipients with hepatitis C virus infection.
    Jain A; Orloff M; Abt P; Kashyap R; Mohanka R; Lansing K; Bozorgzadeh A
    Transplant Proc; 2005 Sep; 37(7):3162-4. PubMed ID: 16213337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recipient age affects long-term outcome and hepatitis C recurrence in old donor livers following transplantation.
    Selzner M; Kashfi A; Selzner N; McCluskey S; Greig PD; Cattral MS; Levy GA; Lilly L; Renner EL; Therapondos G; Adcock LE; Grant DR; McGilvray ID
    Liver Transpl; 2009 Oct; 15(10):1288-95. PubMed ID: 19790152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of hepatitis C virus-positive grafts in liver transplantation: a single-centre experience.
    Ricchiuti A; Brunati A; Mirabella S; Pierini A; Franchello A; Salizzoni M
    Transplant Proc; 2005; 37(6):2569-70. PubMed ID: 16182746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extended criteria donors in liver transplantation: adapting donor quality and recipient.
    Gastaca M
    Transplant Proc; 2009 Apr; 41(3):975-9. PubMed ID: 19376402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liver transplantation using donors older than 80 years: a single-center experience.
    Petridis I; Gruttadauria S; Nadalin S; Viganò J; di Francesco F; Pietrosi G; Fili' D; Montalbano M; D'Antoni A; Volpes R; Arcadipane A; Vizzini G; Gridelli B
    Transplant Proc; 2008; 40(6):1976-8. PubMed ID: 18675105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term survival of recipients of liver grafts from donors older than 80 years: is it achievable?
    Cescon M; Grazi GL; Ercolani G; Nardo B; Ravaioli M; Gardini A; Cavallari A
    Liver Transpl; 2003 Nov; 9(11):1174-80. PubMed ID: 14586878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liver transplantation using young pediatric donor grafts in adults with hepatitis C infection.
    Ghabril M; Dickson RC; Krishna M; Bonatti H; Aranda-Michel J; Keaveny AP; Satyanarayana R; Hewitt W; Hughes CB; Nguyen JH
    Transplantation; 2009 Apr; 87(8):1174-9. PubMed ID: 19384164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival and hepatitis C virus recurrence after liver transplantation in HIV- and hepatitis C virus-coinfected patients: experience in a single center.
    Testillano M; Fernandez JR; Suarez MJ; Gastaca M; Bustamante J; Pijoan JI; Montejo M; Valdivieso A; Ruiz P; Gonzalez J; Ortiz de Urbina J
    Transplant Proc; 2009 Apr; 41(3):1041-3. PubMed ID: 19376421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liver transplant for hepatitis C virus: effect of using older donor grafts on short- and medium-term survival.
    Doyle MB; Anderson CD; Vachharajani N; Lowell JA; Shenoy S; Lisker-Melman M; Korenblat K; Crippin JS; Chapman WC
    Arch Surg; 2008 Jul; 143(7):679-85; discussion 685. PubMed ID: 18645111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contribution of marginal donors to liver transplantation for hepatitis C virus infection.
    Briceño J; Ciria R; Pleguezuelo M; Naranjo A; Sánchez-Hidalgo J; Ruiz-Rabelo J; López-Cillero P; Luque A; de la Mata M; Rufián S
    Transplant Proc; 2007 Sep; 39(7):2297-9. PubMed ID: 17889169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Older donor livers show early severe histological activity, fibrosis, and graft failure after liver transplantation for hepatitis C.
    Rayhill SC; Wu YM; Katz DA; Voigt MD; Labrecque DR; Kirby PA; Mitros FA; Kalil RS; Miller RA; Stolpen AH; Schmidt WN
    Transplantation; 2007 Aug; 84(3):331-9. PubMed ID: 17700157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liver transplantation in the United States.
    Qiu J; Ozawa M; Terasaki PI
    Clin Transpl; 2005; ():17-28. PubMed ID: 17424722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of donor age on survival in liver transplantation due to hepatitis C virus.
    Tallón Aguilar L; Molina García D; Barrera Pulido L; Pareja Ciuró F; Suárez Artacho G; Alamo Martínez JM; Bernal Bellido C; García González I; Serrano Díaz-Canedo J; Gómez Bravo MA; Bernardos Rodríguez A
    Transplant Proc; 2008 Nov; 40(9):2968-70. PubMed ID: 19010162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Donor livers with steatosis are safe to use in hepatitis C virus-positive recipients.
    Burra P; Loreno M; Russo FP; Germani G; Galligioni A; Senzolo M; Cillo U; Zanus G; Fagiuoli S; Rugge M
    Liver Transpl; 2009 Jun; 15(6):619-28. PubMed ID: 19479805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.